Nanomaterials promise to improve disease diagnosis and treatment by enhancing the
delivery of drugs, genes, biomolecules and imaging agents to specific subcellular targets. In …

Phagocytes are key cellular participants determining important aspects of host exposure to
nanomaterials, initiating clearance, biodistribution and the tenuous balance between host …

Nanoparticles are tiny materials (< 1000 nm in size) that have specific physicochemical
properties different to bulk materials of the same composition and such properties make …

With the rapid development of biotechnology and nanomedicine, extensive research has
focused on the investigations of delivering large-cargo molecules using nanoparticles …

Nanoparticles are materials with overall dimensions in the nanoscale, ie, under 100 nm. In
recent years, these materials have emerged as important players in modern medicine, with …

Nanoparticles may address challenges by human diseases through improving diagnosis,
vaccination and treatment. The uptake mechanism regulates the type of threat a particle …

Nanoparticles have unique physicochemical properties which make them promising
platforms for drug delivery. However, immune cells in the bloodstream (such as monocytes …

Nanoparticles are often engineered as a scaffolding system to combine targeting, imaging
and/or therapeutic moieties into a unitary agent. However, mostly overlooked, the …

Although much progress has been made in treating cancers, cancer death rates in and
around the United States are still high. Current treatments are either ineffective against some …

Nanoparticles are considered a primary vehicle for targeted therapies because they can
pass biological barriers and enter and distribute within cells by energy-dependent …